MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: Hematology-Oncology
Hematology-Oncology

Metformin Triggers Ferroptosis in AML Through Lipid Remodeling: A Repurposing Opportunity for Metabolic Subtypes

MedXY Editorial TeamNov 22, 2025
AMLferroptosisLipid Metabolismmetformin

Highlight

– Metformin induces reactive oxygen species (ROS) and ferroptotic cell death in primary AML samples ex vivo, with greatest effect in cases having disrupted lipid metabolism (notably IDH2- and FLT3-mutant disease).

– Lipidomic remodeling with increased triglycerides and polyunsaturated fatty acids (PUFAs), upregulation of lipid-droplet genes including DGAT1, and CD36-mediated uptake are key determinants of metformin sensitivity.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Decoding Post-CD7 CAR-T EBV-Positive Lymphoproliferative Disorder: Insights from Multi-Omics and Spatial Profiling

Hematology-OncologyNov 5, 2026

Estimating the National Impact of Severe Hemolytic Disease of the Fetus and Newborn in the United States

Hematology-OncologyNov 4, 2026

Unraveling Donor Cell-Derived Hematologic Neoplasms: Insights from Spanish Transplant Centers

Hematology-OncologyNov 3, 2026
Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story